MASSACHUSETTS BIOTECHNOLOGY COUNCIL

PARK STREET STRATEGIES, LLC representing MASSACHUSETTS BIOTECHNOLOGY COUNCIL · Q1 2026 · $15,000 · view on lda.senate.gov ↗

Issues lobbied

MMMMedicare/Medicaid
Monitor health and tax legislation related to biotechnology industry.

Key facts

Filing UUID: af757b88-188e-4f6f-83b6-b9552d7c4fe4
Filing type: Q1
Filing period: first_quarter
Filing year: 2026
Posted: 2026-05-04T14:43:33-04:00
Registrant (lobbyist): PARK STREET STRATEGIES, LLC
Client: MASSACHUSETTS BIOTECHNOLOGY COUNCIL
Client location: MA / US
Client description: Trade association dedicated to advancing research
Income reported: $15,000
Expenses reported: —